The Clinical Core of the Johns Hopkins Alzheimer s Disease Research Center (ADRC) s a shared resource available to investigators at Johns Hopkins and elsewhere interested in or conducting clinical or translational research in the cognitive disorders field. Working closely with the Education Core, the Data Core, and Neuropathology Core, the Clinical Core strives to: (1) support funded investigators at Johns Hopkins with key resources, (2) further the research mission of the JHADRC, and (3) promote new and expanded research activities locally and nationally in this complex field. The Core supports the full range of research related activities unique to the field and advises investigators on study design, recruitment, clinical measurement, clinical operations, bio-specimen management (collection, processing, storage), and autopsy research. Central to the Clinical Core s mission is the recruitment and longitudinal characterization of a range of diverse research subjects who participate in investigations associated with the JHADRC. A priority is given to maintaining the current level of representation of minorities, African-Americans in particular, among the study subjects.
The specific aims of the Clinical Core are to: (1) recruit and follow a diverse cohort of subjects, (2) perform annual standardized medical, neurologic, psychiatric and neuropsychological evaluations on all subjects in the Core, (3) provide well-characterized subjects to IRB-approved research associated with the JHADRC, (4) maintain a high autopsy rate (>70% of deceased autopsied), (5) assist the Neuropathology Core in collecting plasma, serum, and DNA from normal controls, individuals with MCI, and cases of AD and related dementias, and to complete APOE genotyping on all subjects, (6) participate in collaborative research with other ADRCs and ADCs and the ADCS, including multi-center therapeutic clinical trials related to AD, and (7) share clinical data with the National Alzheimer Coordinating Center (NACC), and with other investigators conducting multi-center analyses of clinical data. The Clinical Core has contributed importantly to the many innovative findings concerning AD and related disorders emerging from the JHADRC. Additionally, through efforts of our Core, a number of successful novel clinical trials have been reported and are likely to lead to improved care for patients in the coming years.

Public Health Relevance

CLINICAL CORE CORE B: PROJECT NARRATIVE The Johns Hopkins Alzheimer s Disease Research Center is an integrated program aimed at finding improved treatments for patients with Alzheimer disease and related disorders. Complimentary activities within the center include clinical and basic research studies that incorporate state-of-the art methodologies, and contribute significantly to national programs. We are dedicated to training the next generation of investigators and to reaching out to the community to improve understanding about these diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-35
Application #
9462692
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
35
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Seddighi, Sahba; Varma, Vijay R; An, Yang et al. (2018) SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging. J Alzheimers Dis 61:401-414
Fredericks, Carolyn A; Sturm, Virginia E; Brown, Jesse A et al. (2018) Early affective changes and increased connectivity in preclinical Alzheimer's disease. Alzheimers Dement (Amst) 10:471-479
Holingue, Calliope; Wennberg, Alexandra; Berger, Slava et al. (2018) Disturbed sleep and diabetes: A potential nexus of dementia risk. Metabolism 84:85-93
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
van Bergen, Jiri M G; Li, Xu; Quevenco, Frances C et al. (2018) Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old. Neurobiol Aging 64:68-75
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Kim, Sangjune; Yun, Seung Pil; Lee, Saebom et al. (2018) GBA1 deficiency negatively affects physiological ?-synuclein tetramers and related multimers. Proc Natl Acad Sci U S A 115:798-803
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Hohman, Timothy J; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol 75:989-998

Showing the most recent 10 out of 830 publications